Clinical Trial Update: Intra-nasal Naloxone for Treatment of Impaired Awareness of Hypoglycemia [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 clinical trial evaluating intranasal naloxone for treating impaired awareness of hypoglycemia in type 1 diabetes was terminated, with results posted…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypoglycemia Unawareness
• Type 1 Diabetes Mellitus

Drugs mentioned

• Naloxone (Naloxone)

Snippet

Sponsor: University of Minnesota | Conditions: Hypoglycemia Unawareness, Type 1 Diabetes | Phase 1, Phase 2 | Status: TERMINATED | Results posted: 2023-03-27